Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American…

By K. Alberti, R. Eckel, S. Grundy, P. Zimmet, J. Cleeman, K. Donato, J. Fruchart, W. James, C. Loria, Sidney C. Smith. Circulation, 2009

13,278 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology

View Paper: https://www.semanticscholar.org/paper/0671fc91e56dc166dd17fcc52fe72b13df1e5329

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

In Pharmacology

I. Graham

Citations in the corpus

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “7 Metabolic syndrome The metabolic syndrome is variably defined, especially because of different definitions of central obesity, although a so-called harmonized definition was presented in 2009 [514].”
Prevalence and trends of Metabolic Syndrome in the adult US population, 1999–2010 (2013, methodology): “The most recent harmonized definition of MetS has consistent cutoffs for all risk factors, but recommends that the cutoff values for abdominal obesity be selected based on the study or population being examined (3).”
A Comprehensive Review on Metabolic Syndrome (2014, background): “MetS confers a 5-fold increase in the risk of type 2 diabetes mellitus (T2DM) and 2-fold the risk of developing cardiovascular disease (CVD) over the next 5 to 10 years [1].”
The Epidemiology of Obesity: A Big Picture (2015, background): “predisposing individuals to cardiovascular disease and related conditions [8].”
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011, methodology): “Criteria for central obesity as defined by the International Diabetes Federation are given in Table 10.(95) Body weight reduction, even if modest (5–10% of basal body weight), improves lipid abnormalities and favourably affects the other CV risk factors often present in dyslipidaemic individuals.”